1-6 of 6
Vladimir Y Melnichenko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis

Andrei A Novik, Aleksey N Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrei V Kartashov, Tatyana I Ionova, Kira A Kurbatova, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 372.
https://doi.org/10.1182/blood.V116.21.372.372
Published: 2010
Journal Articles

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Andrei A. Novik, MD, FRCP, Alexey N. Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrey Kartashov, Ruslana V Kruglina, Tatiana I Ionova, Kira Kurbatova, Gary J Gorodokin
Journal: Blood
Blood (2009) 114 (22): 2317.
https://doi.org/10.1182/blood.V114.22.2317.2317
Published: 2009
Journal Articles

Mini-Autologous Hematopoietic Stem Cell Transplantations as a New Treatment Modality for Multiple Sclerosis Patients

Andrei A Novik, Vladimir Y Melnichenko, Denis A Fedorenko, Ruslana V Kruglina, Tatiana I Ionova, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin
Journal: Blood
Blood (2008) 112 (11): 4454.
https://doi.org/10.1182/blood.V112.11.4454.4454
Published: 2008
Journal Articles

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Andrei A. Novik, MD, FRCP, Boris V Afanasyev, Igor A Lisukov, Oleg A Rykavicin, Alexandr A Myasnikov, Tatiana I Ionova, Vladimir Y Melnichenko, Denis A Fedorenko, Nina E Osipova, Artur E Zdorov, Ruslana V Kruglina, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin
Journal: Blood
Blood (2008) 112 (11): 4432.
https://doi.org/10.1182/blood.V112.11.4432.4432
Published: 2008
Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris V. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatiana I. Ionova, PhD, Sergey V. Shamanski, MD,PhD, Andrey D. Kulagin, MD,PhD, Olga A. Malysheva, MD, Nikolay I. Baziy, MD,PhD, Vladimir Y. Melnichenko, MD,PhD, Denis A. Fedorenko, MD,PhD, Inna V. Vereschagina, MD, Andrey E. Zdorov, MD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Yury N. Fedotov, MD,PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2006) 108 (11): 3072.
https://doi.org/10.1182/blood.V108.11.3072.3072
Published: 2006
Journal Articles

Clinical and Quality of Life Outcomes in Patients with Multiple Sclerosis (MS) after High Dose Chemotherapy(HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andri A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Yury N. Fedotov, MD, Tatiana I. Ionova, PhD, Alexandr D. Kulagin, PhD, Olga A. Malysheva, MD, Gennadi N. Bisaga, PhD, Vladimir Y. Melnichenko, PhD, Lubov V. Chelombit, MD, Sergei V. Voloshin, PhD, Denis A. Fedorenko, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD
Journal: Blood
Blood (2004) 104 (11): 1875.
https://doi.org/10.1182/blood.V104.11.1875.1875
Published: 2004